Astrazeneca Plc Adr Stock Total Asset

AZN Stock  USD 67.75  0.51  0.75%   
AstraZeneca PLC ADR fundamentals help investors to digest information that contributes to AstraZeneca PLC's financial success or failures. It also enables traders to predict the movement of AstraZeneca Stock. The fundamental analysis module provides a way to measure AstraZeneca PLC's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to AstraZeneca PLC stock.
As of the 29th of March 2024, Total Assets is likely to grow to about 106.2 B.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

AstraZeneca Total Asset Analysis

AstraZeneca PLC's Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
 2021 2022 2023 2024 (projected)
Interest Expense1.3B1.3B1.6B1.7B
Depreciation And Amortization6.5B5.6B4.9B5.2B

Total Asset

 = 

Tangible Assets

+

Intangible Assets

More About Total Asset | All Equity Analysis

Current AstraZeneca PLC Total Asset

    
  101.12 B  
Most of AstraZeneca PLC's fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AstraZeneca PLC ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

AstraZeneca Total Asset Driver Correlations

Understanding the fundamental principles of building solid financial models for AstraZeneca PLC is extremely important. It helps to project a fair market value of AstraZeneca Stock properly, considering its historical fundamentals such as Total Asset. Since AstraZeneca PLC's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of AstraZeneca PLC's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of AstraZeneca PLC's interrelated accounts and indicators.
0.340.90.85-0.380.3-0.360.960.690.790.930.740.910.960.430.791.0-0.190.830.50.83-0.660.69-0.360.60.680.630.80.090.85
0.340.40.120.22-0.580.070.250.140.450.39-0.080.140.27-0.02-0.10.350.00.01-0.270.19-0.05-0.120.08-0.040.3-0.20.08-0.590.19
0.90.40.65-0.20.11-0.220.740.760.750.970.690.70.820.080.570.91-0.060.650.470.8-0.30.410.010.260.480.510.84-0.040.87
0.850.120.65-0.780.23-0.530.890.340.730.790.650.910.90.480.810.86-0.440.870.610.86-0.830.84-0.460.820.830.70.810.150.86
-0.380.22-0.2-0.78-0.030.6-0.470.13-0.47-0.37-0.35-0.58-0.49-0.23-0.49-0.410.63-0.62-0.68-0.690.63-0.720.33-0.68-0.69-0.65-0.59-0.12-0.65
0.3-0.580.110.23-0.03-0.060.40.44-0.050.120.510.330.320.530.620.280.320.360.10.0-0.390.42-0.490.360.010.310.150.650.05
-0.360.07-0.22-0.530.6-0.06-0.420.1-0.28-0.32-0.22-0.39-0.47-0.3-0.4-0.360.48-0.39-0.44-0.490.44-0.490.36-0.41-0.43-0.44-0.43-0.09-0.46
0.960.250.740.89-0.470.4-0.420.580.730.810.690.950.960.620.860.95-0.270.860.480.77-0.820.82-0.570.760.740.660.70.170.75
0.690.140.760.340.130.440.10.580.420.650.810.560.550.150.630.670.180.630.30.46-0.120.39-0.010.240.330.530.590.250.5
0.790.450.750.73-0.47-0.05-0.280.730.420.810.530.710.760.130.460.82-0.110.660.50.8-0.50.58-0.10.480.680.560.7-0.410.8
0.930.390.970.79-0.370.12-0.320.810.650.810.710.760.90.190.650.95-0.110.710.460.83-0.470.51-0.110.410.60.530.9-0.020.92
0.74-0.080.690.65-0.350.51-0.220.690.810.530.710.680.720.380.870.74-0.020.860.480.62-0.470.72-0.250.590.540.770.810.270.68
0.910.140.70.91-0.580.33-0.390.950.560.710.760.680.880.470.830.89-0.430.920.650.85-0.750.86-0.440.780.820.770.730.230.8
0.960.270.820.9-0.490.32-0.470.960.550.760.90.720.880.560.820.97-0.220.810.460.79-0.780.73-0.470.680.660.590.80.110.83
0.43-0.020.080.48-0.230.53-0.30.620.150.130.190.380.470.560.660.42-0.130.45-0.050.1-0.830.61-0.930.680.30.240.140.340.09
0.79-0.10.570.81-0.490.62-0.40.860.630.460.650.870.830.820.660.78-0.190.90.450.61-0.770.86-0.560.830.670.740.710.450.63
1.00.350.910.86-0.410.28-0.360.950.670.820.950.740.890.970.420.78-0.170.820.50.84-0.660.69-0.350.590.680.630.820.040.87
-0.190.0-0.06-0.440.630.320.48-0.270.18-0.11-0.11-0.02-0.43-0.22-0.13-0.19-0.17-0.4-0.61-0.530.31-0.450.22-0.4-0.49-0.48-0.28-0.17-0.38
0.830.010.650.87-0.620.36-0.390.860.630.660.710.860.920.810.450.90.82-0.40.690.82-0.690.93-0.40.830.830.910.80.240.78
0.5-0.270.470.61-0.680.1-0.440.480.30.50.460.480.650.46-0.050.450.5-0.610.690.83-0.280.65-0.020.430.520.860.660.120.74
0.830.190.80.86-0.690.0-0.490.770.460.80.830.620.850.790.10.610.84-0.530.820.83-0.490.71-0.130.540.770.810.87-0.020.96
-0.66-0.05-0.3-0.830.63-0.390.44-0.82-0.12-0.5-0.47-0.47-0.75-0.78-0.83-0.77-0.660.31-0.69-0.28-0.49-0.810.8-0.89-0.64-0.47-0.44-0.2-0.48
0.69-0.120.410.84-0.720.42-0.490.820.390.580.510.720.860.730.610.860.69-0.450.930.650.71-0.81-0.610.910.80.880.620.230.63
-0.360.080.01-0.460.33-0.490.36-0.57-0.01-0.1-0.11-0.25-0.44-0.47-0.93-0.56-0.350.22-0.4-0.02-0.130.8-0.61-0.61-0.32-0.25-0.07-0.33-0.08
0.6-0.040.260.82-0.680.36-0.410.760.240.480.410.590.780.680.680.830.59-0.40.830.430.54-0.890.91-0.610.790.680.480.210.48
0.680.30.480.83-0.690.01-0.430.740.330.680.60.540.820.660.30.670.68-0.490.830.520.77-0.640.8-0.320.790.710.610.020.69
0.63-0.20.510.7-0.650.31-0.440.660.530.560.530.770.770.590.240.740.63-0.480.910.860.81-0.470.88-0.250.680.710.720.190.72
0.80.080.840.81-0.590.15-0.430.70.590.70.90.810.730.80.140.710.82-0.280.80.660.87-0.440.62-0.070.480.610.720.130.95
0.09-0.59-0.040.15-0.120.65-0.090.170.25-0.41-0.020.270.230.110.340.450.04-0.170.240.12-0.02-0.20.23-0.330.210.020.190.130.02
0.850.190.870.86-0.650.05-0.460.750.50.80.920.680.80.830.090.630.87-0.380.780.740.96-0.480.63-0.080.480.690.720.950.02
Click cells to compare fundamentals

AstraZeneca Total Asset Historical Pattern

Today, most investors in AstraZeneca PLC Stock are looking for potential investment opportunities by analyzing not only static indicators but also various AstraZeneca PLC's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total asset growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of AstraZeneca PLC total asset as a starting point in their analysis.
   AstraZeneca PLC Total Asset   
       Timeline  
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
Competition

AstraZeneca Total Assets

Total Assets

106.17 Billion

At this time, AstraZeneca PLC's Total Assets are very stable compared to the past year.
Based on the latest financial disclosure, AstraZeneca PLC ADR has a Total Asset of 101.12 B. This is much higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The total asset for all United States stocks is significantly lower than that of the firm.

AstraZeneca Total Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AstraZeneca PLC's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of AstraZeneca PLC could also be used in its relative valuation, which is a method of valuing AstraZeneca PLC by comparing valuation metrics of similar companies.
AstraZeneca PLC is currently under evaluation in total asset category among related companies.

AstraZeneca PLC Institutional Holders

Institutional Holdings refers to the ownership stake in AstraZeneca PLC that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of AstraZeneca PLC's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing AstraZeneca PLC's value.
Shares
Franklin Resources Inc2023-12-31
9.8 M
Atlantic Trust Group, Llc2023-09-30
9.5 M
Capital World Investors2023-12-31
9.3 M
Fisher Asset Management, Llc2023-09-30
9.2 M
Putnam Investments Llc2023-12-31
7.7 M
Blackrock Inc2023-09-30
6.4 M
Farallon Capital Management, L.l.c.2023-09-30
6.1 M
Nuveen Asset Management, Llc2023-09-30
5.3 M
Amvescap Plc.2023-09-30
4.9 M
T. Rowe Price Associates, Inc.2023-12-31
52.3 M
Wellington Management Company Llp2023-12-31
49.4 M

AstraZeneca Fundamentals

About AstraZeneca PLC Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze AstraZeneca PLC ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AstraZeneca PLC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AstraZeneca PLC ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2024
Total Assets101.1 B106.2 B

Pair Trading with AstraZeneca PLC

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AstraZeneca PLC position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AstraZeneca PLC will appreciate offsetting losses from the drop in the long position's value.

Moving against AstraZeneca Stock

  0.48MGNX MacroGenics Financial Report 14th of May 2024 PairCorr
The ability to find closely correlated positions to AstraZeneca PLC could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AstraZeneca PLC when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AstraZeneca PLC - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AstraZeneca PLC ADR to buy it.
The correlation of AstraZeneca PLC is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AstraZeneca PLC moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AstraZeneca PLC ADR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AstraZeneca PLC can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether AstraZeneca PLC ADR offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AstraZeneca PLC's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Astrazeneca Plc Adr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Astrazeneca Plc Adr Stock:
Check out AstraZeneca PLC Piotroski F Score and AstraZeneca PLC Altman Z Score analysis.
Note that the AstraZeneca PLC ADR information on this page should be used as a complementary analysis to other AstraZeneca PLC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Complementary Tools for AstraZeneca Stock analysis

When running AstraZeneca PLC's price analysis, check to measure AstraZeneca PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AstraZeneca PLC is operating at the current time. Most of AstraZeneca PLC's value examination focuses on studying past and present price action to predict the probability of AstraZeneca PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AstraZeneca PLC's price. Additionally, you may evaluate how the addition of AstraZeneca PLC to your portfolios can decrease your overall portfolio volatility.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Commodity Directory
Find actively traded commodities issued by global exchanges
Global Correlations
Find global opportunities by holding instruments from different markets
Is AstraZeneca PLC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AstraZeneca PLC. If investors know AstraZeneca will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AstraZeneca PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.059
Dividend Share
2.9
Earnings Share
1.9
Revenue Per Share
2.4547
Quarterly Revenue Growth
0.073
The market value of AstraZeneca PLC ADR is measured differently than its book value, which is the value of AstraZeneca that is recorded on the company's balance sheet. Investors also form their own opinion of AstraZeneca PLC's value that differs from its market value or its book value, called intrinsic value, which is AstraZeneca PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AstraZeneca PLC's market value can be influenced by many factors that don't directly affect AstraZeneca PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AstraZeneca PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if AstraZeneca PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AstraZeneca PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.